Work

Incidence and risk of treatment-related mortality in cancer patients treated with the mammalian target of rapamycin inhibitors

Year: 2013

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Annals of Oncology

DOI: 10.1093/annonc/mdt155

Authors: T.K. Choueiri, Y. Je, G. Sonpavde, C.J. Richards, M.D. Galsky, P.L. Nguyen, F. Schutz, D.Y. Heng, M.D. Kaymakcalan

Institutions: Dana-Farber Cancer Institute, Kyung Hee University, University of Alabama at Birmingham, Beth Israel Deaconess Medical Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Brigham and Women's Hospital, Hospital São Paulo, University of Calgary

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2115753233

FWCI: 0.533

Cites: 34

Cited by: 35

Related to: 10